Frankfurt
24.04.25
09:16 Uhr
2,570 Euro
+0,040
+1,58 %
+1,58 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Bactiguard Holding AB: Bactiguard Holding AB's interim report first quarter 2025 | 4 | GlobeNewswire (Europe) | Continued profitability and revenue growth for Bactiguard
First quarter 2025 (January - March)
Total revenue amounted to SEK 62.7 (58.8) million, an increase of SEK 3.9 million corresponding to 6.7%.
Net... ► Artikel lesen | |
| BACTIGUARD Aktie jetzt für 0€ handeln | |||||
| 17.04. | BACTIGUARD HOLDING AB: Bactiguard Holding AB's Annual and Sustainability Report 2024 | 1 | Cision News | ||
| 16.04. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's interim report for the first quarter 2025 | 1 | Cision News | ||
| 10.04. | BACTIGUARD HOLDING AB: Notice to attend the Annual General Meeting of Bactiguard Holding AB | 1 | Cision News | ||
| 03.04. | BACTIGUARD HOLDING AB: The Nomination Committee's proposal for Board of Directors to the 2025 Annual General Meeting | 2 | Cision News | ||
| 05.03. | BACTIGUARD HOLDING AB: Bactiguard announces updated strategic and financial targets | 3 | Cision News | ||
| 06.02. | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2024 | 94 | GlobeNewswire (Europe) | License focused strategy delivered increased revenues and profitability
Fourth quarter 2024 (October - December)
Total revenue amounted to SEK ?68.3? (?61.3?) million, an increase of SEK ?6.9?... ► Artikel lesen | |
| 30.01. | BACTIGUARD HOLDING AB: Invitation to presentation of Bactiguard's year-end report for 2024 | 3 | Cision News | ||
| 11.11.24 | BACTIGUARD HOLDING AB: Nomination Committee appointed for Bactiguard Holding AB's Annual General Meeting 2025 | 1 | Cision News | ||
| 24.10.24 | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2024 | 195 | GlobeNewswire (Europe) | Bactiguard delivers positive EBITDA and initiates review of 2028 financial targets due to previously announced agreement termination
Third quarter 2024 (July - September)
Total revenue amounted to... ► Artikel lesen | |
| 02.10.24 | Bactiguard Holding AB: Zimmer Biomet terminates agreement for multiple orthopedic product segments - trauma agreement remains in effect | 373 | GlobeNewswire (Europe) | Zimmer Biomet has informed Bactiguard that they terminate the license agreement signed in 2022 covering multiple orthopedic product segments. The reason stated is the more complex and lengthier path... ► Artikel lesen | |
| 16.07.24 | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2024 | 178 | GlobeNewswire (Europe) | License revenues and EBITDA stabilizing
Second quarter 2024 (April - June)
Total revenue amounted to SEK 60.9 (51.2) million, an increase of SEK 9.7 million corresponding to 18.9%.
Net sales amounted... ► Artikel lesen | |
| 25.04.24 | Bactiguard Holding AB: Bactiguard Holding AB's interim report first quarter 2024 | 248 | GlobeNewswire (Europe) | Strategic transformation concluded and new leadership in place
First quarter 2024 (January - March)
Total revenue amounted to SEK 58.8 (61.2) million, a decrease of SEK 2.4 million, corresponding... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 6,401 | +2,78 % | Jefferies cuts Teladoc price target to $8, maintains hold rating | ||
| ROKU | 56,50 | +2,21 % | Roku Introduces New Device Line-Up: Buy, Sell or Hold the Stock? | ||
| SERNOVA BIOTHERAPEUTICS | 0,133 | -1,48 % | Sernova Biotherapeutics Inc: Sernova closes $4-million term loan from Navigate | ||
| SYNLAB | 12,780 | -0,16 % | Fitch ändert Synlabs Ausblick auf stabil, bestätigt 'B' IDR | ||
| BOSTON SCIENTIFIC | 89,00 | +1,83 % | Boston Scientific: Jon Monson To Succeed Brennan As CFO | WASHINGTON (dpa-AFX) - Boston Scientific (BSX) announced that Dan Brennan, executive vice president and chief financial officer, has elected to retire. Brennan will transition out of the chief... ► Artikel lesen | |
| PAUL HARTMANN | 257,00 | +3,63 % | Paul Hartmann-Aktie // Gute Aussichten bei günstiger Bewertung | Paul Hartmann meldet ein erfolgreiches Geschäftsjahr 2024 und strebt für 2025 weitere Ergebnisverbesserung an. Die Aktie befindet sich in einer charttechnisch reizvollen Situation.
Quelle .. Den vollständigen... ► Artikel lesen | |
| SYSMEX | 16,100 | -3,59 % | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
| ADDLIFE | 14,080 | -1,88 % | AddLife AB: Year-end Report 1 January - 31 December 2024 | AddLife finishes the year with high growth, improved margins, and strong cash flow
"AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash... ► Artikel lesen | |
| EMBECTA | 10,200 | +2,51 % | Embecta Corp.: embecta to Report Fiscal Second Quarter 2025 Financial Results | ||
| ENOVIS | 28,000 | -6,67 % | Enovis Corporation: Enovis Announces Appointment of Damien McDonald as Chief Executive Officer | Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis Corporation... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.11.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 19.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.11.2024ISIN NameAU000000SVW5 SEVEN... ► Artikel lesen | |
| FRESENIUS | 39,850 | +0,94 % | Fresenius SE Aktie: Leichte Erholung im Fokus | Fresenius notiert nahe dem Jahreshoch mit soliden technischen und fundamentalen Signalen. Analysten sehen weiteres Kurspotenzial trotz hoher Verschuldung. Die Fresenius-Aktie zeigt sich am Donnerstag... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,880 | +0,55 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
| BRIGHTSPRING HEALTH SERVICES | 16,550 | +1,72 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen |
Das Unternehmen BACTIGUARD HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,570 Euro und damit +1,58 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BACTIGUARD HOLDING AB finden Sie auf Wallstreet Online.
